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Abstract
Purpose Adverse effects of maternal vitamin D deficiency have been linked to adverse pregnancy outcomes. We investigated the
relationship between maternal vitamin D status and newborn anthropometry measurements using a genetic approach and
examined the interaction between genetic variations in involved in vitamin D synthesis and metabolism and maternal vitamin
D concentrations on newborn anthropometry.
Methods The study was conducted in 183 pregnant Indonesian Minangkabau women. Genetic risk scores (GRSs) were created
using six vitamin D–related single nucleotide polymorphisms and their association with 25-hydroxyvitamin D [25(OH)D] levels
and newborn anthropometry (183 infants) were investigated.
Results There was no significant association between maternal 25(OH)D concentrations and newborn anthropometry measure-
ments (P > 0.05, for all comparisons). After correction for multiple testing using Bonferroni correction, GRS was significantly
associated with 25(OH)D in the third trimester (P = 0.004). There was no association between GRS and newborn anthropometric
measurements; however, there was an interaction betweenGRS and 25(OH)D on head circumference (P = 0.030), wheremothers
of neonates with head circumference < 35 cm had significantly lower 25(OH)D if they carried ≥4 risk alleles compared to those
who carried ≤3 risk alleles.
Conclusion Our findings demonstrate the impact of vitamin D-related GRS on 25(OH)D and provides evidence for the effect of
vitamin D-related GRS on newborn anthropometry through the influence of serum 25(OH)D levels among Indonesian pregnant
women. Even though our study is a prospective cohort, before the implementation of vitamin D supplementation programs in
Indonesia to prevent adverse pregnancy outcomes, further large studies are required to confirm our findings.
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Introduction
As one of the tropical countries in Southeast Asia located at
the equator, Indonesia has an abundant sunlight all year round.
According to recent studies, vitamin D deficiency in
Indonesian women ranges between 60 and 95% [1–5].
Adequacy of maternal vitamin D status is important for the
development of bone, teeth, immune system and general
growth of the foetus [5]. Vitamin D insufficiency during preg-
nancy have been shown to be associated with adverse preg-
nancy outcomes such as small-for-gestational-age (SGA),
neurodevelopment and cognitive impairment, high blood
pressure in women and infants, respiratory infections, in-
creased incidence of infants treated in neonatal intensive care
unit, and health outcomes in infants such as asthma, atopic
allergy, and autoimmune disorders such as type 1 diabetes
mellitus [6–11].
Hereditary factors have been shown to affect 29% to 80%
of serum 25-hydroxyvitamin D [25(OH)D] concentrations
[11]. Candidate gene studies have identified twelve genes
based on the genome-wide association studies (GWAS) for
25(OH)D (GC, CYP24A1, CYP2R1, DHCR7) [12], GWAS
for skin colour/tanning (interferon regulatory factor 4
(IRF4); melanocortin 1 receptor (MC1R); oculocutaneous al-
binism type 2 (OCA2); solute carrier family 45, member 2
(SLC45A2); tyrosinase (oculocutaneous) (TYR)) [13–15],
and candidate gene studies for vitamin D pathway genes
(VDR, cytochrome P450, family 27, subfamily A, polypeptide
1 (CYP27A1); cytochrome P450, family 27, subfamily B,
polypeptide 1 (CYP27B1)) [16]. Recent GWASs have con-
firmed the association of six genetic variants in the following
genes (short/branched chain acyl-CoA dehydrogenase
(ACADSB), GC, DHCR7, CYP2R1, and CYP24A1) with
25OHD levels [12, 17], and these variants were found near
genes involved in cholesterol synthesis, hydroxylation, and
vitamin D transport that affects vitamin D status. The meta-
bolic pathways and synthesis of vitamin D are regulated by the
specific genes present in the pathway and the pathway is ini-
tiated by the exposure to UVB rays (vitamin D3) and dietary
intake of vitamin D sources (vitamin D2).
Previous GWASs [12, 17] have identified common ge-
netic variations that influence vitamin D status in western
populations; however, very few studies have investigated
the influence of common genetic variations on vitamin D
status in populations within Southeast Asia, especially in
Indonesian population. In this study, we explored the asso-
ciation between maternal vitamin D status and newborn
anthropometry measurements using a genetic approach.
Given the high level of confounding factors that exists
between maternal vitamin D status and newborn anthro-
pometry measurements, we used genetic variants as
markers of maternal vitamin D status and tested for their
association with newborn anthropometry measurements as
genetic associations are less prone to confounding. In ad-
dition, we also investigated whether the association be-
tween genetic variants and newborn anthropometry mea-
surements were modified by 25(OH)D concentrations in
Indonesian pregnant women from West Sumatra.
Methodology
Study population
The study was conducted among singleton pregnant women
of West Sumatran Vitamin D Pregnant Mother (VDPM) co-
hort study inWest Sumatra, from July 2017 to April 2018. The
study was performed at community health centres in five cities
(Padang, Pariaman, Payakumbuh, Padang Pariaman, and
Lima Puluh Kota) in West Sumatra, Indonesia. In this study,
participants were followed up from the first trimester (T1) to
third trimester (T3) of pregnancy and at delivery to determine
newborn anthropometry measurements (birth weight, birth
length and head circumference). This study was conducted
in accordance with the declaration of Helsinki and approved
by the Ethics Committees of Medical Faculty, Andalas
University (No. 262/KEP/FK/2016). All women provided
written informed consent prior to the start of the data
collection.
All participants were pregnant women who were recruit-
ed during their first antenatal care checks at the public
health centres. Inclusion criteria included: 1) pregnant
women willing to visit public health care at each site, 2)
those who were in the T1 (<13 weeks) of their singleton
pregnancy, 3) those who were healthy based on medical
examination, and 4) those who were willing to participate
by signing the informed consent and following the research
procedures. Stratified random sampling was applied for the
data collection that took place at two research locations:
mountainous and coastal areas. Public health centers that
had high numbers of the first-trimester pregnant mothers
were chosen for the data collection. Women were excluded
from the study if they had multiple pregnancies, some
common complications of pregnancy such as preeclamp-
sia, miscarriage or pregnancy loss, stillbirth, and they had
chronic illness like diabetes, hypertension, cardiovascular
disease, or hypothyroidism. Women who were taking
drugs that can interfere with vitamin D metabolism such
as antiepileptic agents, glucocorticoids, anti-oestrogens or
antiretroviral drugs during pregnancy were excluded. Out
of 239 women, 53 were dropped out for different reasons,
including pregnancy loss, change of residence, not willing
to continue research, and those who could not be contacted
again. The number of pregnancy loss due to complications
of pregnancy such as foetal inflammation, stillbirth, and
abnormal foetal development was 25 (13.44%). There were
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3 cases of preterm birth, 8 cases of stillbirth, and 14 cases
of miscarriage. Finally, we obtained 186 pregnant women
who completed all requirements and attended follow-ups
from T1 to delivery. After excluding three samples due to
low DNAyield, a total of 183 mother and infant pairs were
used for the present study. Participant’s recruitment pro-
cess is shown in detail in Fig. 1.
Study Participant’s characteristics
Maternal sociodemographic factors were assessed using a
standardized questionnaire administered by trained field
data collector (enumerator, i.e., a registered nutritionist).
The questionnaire included information on demographics,
maternal occupation, education, and pregnancy profile.
These data were prospectively collected from medical re-
cords or interviews. Maternal sociodemographic character-
istics included age, education level (primary, secondary,
and tertiary levels), maternal working status (working
and not working), and geographical status (mountainous
and coastal area). Maternal health status included pre-
pregnancy BMI, and mid-upper arm circumference
(MUAC). Maternal lifestyle included the outdoor activity
to measure the sun exposure status during pregnancy and
maternal vitamin D and calcium supplementation during
pregnancy.
Fig. 1 Flowchart showing the selection of study participants. Pregnant
womenwho were < 13 weeks of gestation were recruited and followed up
until the delivery to determine newborn anthropometry measurements.
Out of 276 women, 90 were dropped out because of pregnancy loss,
change of residence, not willing to continue research, and those who
could not be contacted again. Out of 186 pregnant women who
completed all requirements and attended follow-ups from the T1 to
delivery, three individuals were excluded due to low DNA yield and
hence a total of 183 mother and infant pairs were used for analysis. T1:
first trimester; T2: second trimester; T3: third trimester
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Anthropometric measurements
Maternal anthropometric measurements (height, weight, and
MUAC) were determined at enrolment and followed up dur-
ing pregnancy. Pre-pregnancy BMI was calculated based on
the height routinely measured at the clinic visit and pre-
pregnancy body weight obtained at interview through mater-
nal and child monitoring book. Maternal body weight was
measured to the nearest 100 g using an electronic scale
(Seca 815, Seca GmbH. Co. kg, Germany) and height was
measured to the nearest millimeter using a stadiometer (Seca
217, Seca GmbH. Co. kg, Germany). The BMI calculation
was based on the body weight (kg) divided by the square of
body height (m). Pre-pregnancy BMI was classified according
to World Health Organization guidelines for Asian popula-
tions (underweight, <18.5 kg/m2; normal, 18.5–23.49 kg/m2;
overweight, 23.5–24.99 kg/m2; Pre-obese, 25–29.99 kg/m2;
Obese, ≥30 kg/m2) [18].
Measuring serum 25-hydroxyvitamin D levels
Maternal blood was collected two times under non-fasting
conditions at <13 and > 27 weeks of gestation. Serum samples
were stored at -70 °C until they were analyzed for 25(OH)D
concentrations. Serum levels of 25(OH)Dwere assessed using
Enzyme-linked immunosorbent assay (ELISA) from
Diagnostic Biochemistry Canada (DBC) 25-Hydroxyvitamin
D ELISA kit (DBC, London, Ontario Canada) and measured
using xMark Microplate Spectrophotometer (Bio-Rad
Laboratories Inc., Hercules, California, USA). The assay had
a sensitivity of 5.5 ng/mL and an intra and inter-assay coeffi-
cient of variation of 5% and 8.1%, respectively. The vitamin D
status was defined as serum 25(OH)D < 12 ng/mL (vitamin D
deficient), 12–19 ng/mL (vitamin D insufficient), ≥20 ng/mL
(vitamin D sufficient) according to Institute of Medicine
(IOM) guidelines [19].
SNP selection and genetic analysis
We selected six candidate SNPs according to the following
criteria: (1) biological importance in vitamin D synthesis, me-
tabolism, transportation, or degradation; (2) SNPs with minor
allele frequency of >5%, and (3) evidence of a significant
association in previous GWASs. The selected genes were
DHCR7 (rs12785878), CYP2R1 (rs12794714), GC
(rs2282679), CYP24A1 (rs6013897), and VDR (rs2228570
and rs7975232) [12, 17, 20] and the roles of these genes in
the vitamin D cascade are shown in Supplementary Fig. 1.
Blood samples were collected from all the study partici-
pants. Genomic DNAwas isolated from peripheral blood leu-
kocytes using PureLink Genomic DNA Mini Kit (Invitrogen,
Carlsbad, USA). The DNA concentration was determined
using a NanoDrop spectrophotometer (Isogen Life Science,
De Meern, the Netherlands). Genotyping was performed at
LGC Genomics, UK (http://www.lgcgroup.com/services/
genotyping). Genotype frequencies were tested against the
Hardy-Weinberg equilibrium (HWE) using the χ2 test.
Genotype frequencies of all SNPs were in Hardy Weinberg
equilibrium and the minor-allele frequencies of the SNPs
ranged from 0.18 to 0.39 (Supplementary Table 1).
Pregnancy outcomes
Gestational age at birth was calculated from estimated gesta-
tional age examined by obstetricians or midwives using
transabdominal ultrasound performed or date of last menstrual
period in the absence of ultrasound at the Maternal Clinic or
Hospital. Infants’ birth weight, birth length, and head circum-
ference were recorded at birth using Seca mechanical measur-
ing scales (Seca 803, Seca GmbH. Co. kg, Hamburg,
Germany). We classified newborn anthropometry status ac-
cording to World Health Organization Child Growth
Standards for head circumference-for-age (small head circum-
ference, <35 cm and normal head circumference, ≥35 cm),
weight-for-age (low birth weight, <2500 g and normal birth
weight ≥ 2500 g), and length-for-age (short birth length,
<50 cm and normal birth length, ≥50 cm) [21].
Sample size and power calculation
The sample size was calculated for investigating the associa-
tion between vitamin D levels and birth weight, which was the
main objective of the VDPM study. Previous study found that
13.08 ng/mL difference of maternal vitamin D level between
mothers of low birth weight neonate and those of normal birth
weight neonate with standard deviation ranging from 18.50 to
20.16 ng/mL [22]. The sample size was calculated using the
following formula [23].
n ¼ 2 Zαþ Zβð Þ
2S2
U1−U2ð Þ2
n Sample size of each group.
Zα Value of standard normal distribution that is equal to
α = 0.05 is 1.96.
Zβ Value of standard normal distribution (90%) that
equal to β = 0.10 is 1,28.
S Outcome standard deviation based on the study by
Khalessi et al. 2015 [23] is 18.5.
(U1-
U2)
Difference of mean outcome in low birthweight and
normal birthweight status (13.08)
n 2 (1,96 + 1,28)2 × 18.52/(13.08)2 = 41.96 ≈ 42.
Based on the above formula, the minimum number of
samples required for each group is 42 to achieve a
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statistical power of 90% to test for the association be-
tween vitamin D levels and birth weight. Hence, we
aimed to recruit a total sample size with minimum of
100 participants to account for a 20% drop-out. Given
that there are no studies, to date, that have examined
the association between genetic variants and vitamin D
levels and adverse pregnancy outcomes in Indonesia, we
were unable to calculate the power for the genetic anal-
ysis. Furthermore, genetic analysis was conducted as a
retrospective post hoc analysis and hence the power
calculation was not performed for the genetic study.
Statistical analysis
Data were analysed using the IBM SPSS Statistics for
Windows (version 23.0; SPSS, Inc., Chicago, IL, USA).
Continuous variables with normal distribution were presented
as mean ± SD. Categorical variables were presented as fre-
quency and percentage. The normality of distribution of out-
come variables (maternal serum 25(OH)D levels) was tested
by Kolmogorov-Smirnov test.
Bivariate Pearson correlation was established to ex-
amine the correlation of serum 25(OH)D levels in the
first trimester with serum 25(OH)D levels in the third
trimester. A multinomial logistic regression model was
used to identify the association between vitamin D sta-
tus during pregnancy and newborn anthropometry status
such as birth weight status, head circumference status,
and birth length status. A multivariate analysis using
general linear model (GLM) was conducted to deter-
mine the association between vitamin D status and new-
born anthropometry. Significant factors associated with
vitamin D status were entered into the GLM to adjust
for covariate variables such as age, pre-pregnancy BMI,
gestational age birth, infant gender, and supplement in-
take during pregnancy.
Genetic risk score (GRS), which was the sum of risk
alleles from the SNPs rs12785878 (DHCR7), rs12794714
(CYP2R1), rs2282679 (GC), rs6013897 (CYP24A1), and
rs2228570 and rs7975232 (VDR) [12, 17, 20], was cre-
ated. Furthermore, GRS was divided into three groups as
“vitamin D-GRS”, “synthesis-GRS” and “metabolism-
GRS”. “Vitamin D-GRS” was obtained from all the six
SNPs that play a role in the synthesis and metabolism of
vitamin D. Two SNPs in genes encoding proteins in-
volved in 25(OH)D synthesis (DHCR7 and CYP2R1)
were included in the “synthesis-GRS” [12] and four
SNPs in genes encoding proteins involved in 25(OH)D
metabolism (GC, CYP24A1, VDR) were included in the
“metabolism-GRS” [20].
The effect of GRSs on 25(OH)D levels and newborn
anthropometry was assessed using univariate general lin-
ear models after adjustment for potential confounders
(age, pre-pregnancy BMI, geography status, vitamin D
and calcium supplement consumption during pregnancy
and sunlight exposure status). The associations of GRSs
with vitamin D status and newborn anthropometry (birth
weight, birth length, head circumferences) were analysed
using logistic regression analysis. The interaction between
GRS and 25(OH)D levels during pregnancy (T1 and T3)
on newborn anthropometry measurements was determined
by including interaction terms [GRS*25(OH)D] in the
model and adjusting for age, pre-pregnancy BMI, gesta-
tional age at birth, and infant’s gender. The study objec-
tives are shown in Fig. 2.
Correction for multiple testing was performed using
Bonferroni correction. Corrected P value for association
analysis was ≤0.006 [3 GRS * 3 maternal 25(OH)D
level outcomes (T1, T3, and changes in 25(OH)D dur-
ing pregnancy) = 9 tests]. For the interaction analysis,
corrected P value was ≤0.003 [3 GRS * 2 maternal
25(OH)D outcomes (T1 and T3) * 3 newborn anthro-
pometry outcomes (birth weight, birth length, and head
circumference) = 18 tests].
Results
Characteristic of the study population
The characteristics of the study participants stratified based on
maternal vitamin D status at T1 and T3 are shown in Table 1.
There was a significant difference in diastolic blood pressure
(DBP), and body weight during the third trimester and there
was a significant difference in outdoor activity (hours/day)
during the first trimester between those who were vitamin D
deficient (VDD) and those with normal vitamin D status
(NVD) (p < 0.05). In Table 1, there was a significant differ-
ence in systolic blood pressure, bodyweight, and MUAC be-
tween T1 and T3 (p < 0.05, for all comparisons). Systolic
blood pressure, bodyweight, and MUAC were significantly
higher in T3 compared to T1. However, there was no signif-
icant difference in the levels of hemoglobin and diastolic
blood pressure (p > 0.05, for all comparisons). The study par-
ticipants were enrolled at an average age of 29.7 ± 5.68 years.
The average of pre-pregnancy Body Mass Index (BMI) was
23.45 ± 4.56 kg/m2. The average gestational duration was
38.88 ± 1.91 weeks and 73.30% of deliveries were normal.
Mean birth weight, birth length, and head circumference were
3204.87 ± 494.99 g, 48.56 ± 2.87 cm, and 33.89 ± 2.52 cm,
respectively. Approximately 6.80% (n = 12) of newborn
babies had low birth weight (LBW) status, while 5.40%
(n = 10) were diagnosed with macrosomia. There were <
10% of cases who had adverse pregnancy outcomes such as
LBW, SGA, and preterm birth (PTB). However, a higher num-
ber of women had babies with a small head circumference
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(<35 cm) and short birth length (<50 cm) (57.30% and
64.10%, respectively).
Vitamin D status during pregnancy
Average maternal serum 25(OH)D level in T1 was 14.00 ±
6.97 ng/mL. Approximately 82.80% (n = 154) of womenwere
deficient (47.30%, n = 88) and insufficient (35.50%, n = 66)
for vitamin D. The serum 25(OH)D levels increased signifi-
cantly during pregnancy (P = 0.0001, R = 0.425). In the T3,
average maternal serum 25(OH)D level was 21.21 ± 10.16 ng/
mL. A total of 46.80% (n = 87) of women were vitamin D
sufficient, 34.40% (n = 64) were insufficient and 18.80%
(n = 35) were deficient. The prevalence of vitamin D deficien-
cy and insufficiency in the T1 lowered from 82.80% (n = 154)
to 53.20% (n = 99) in the T3.
Association between maternal Vitamin D status
during pregnancy and newborn anthropometry
We found no significant association between 25(OH)D level
during T1 and T3 and newborn anthropometric measurements
(P > 0.05 for all comparisons). There was also no significant
association between changes in vitamin D status during preg-
nancy and newborn anthropometry (P > 0.05 for all compari-
sons) (Table 2).
Association between GRS and serum 25(OH)D levels
during pregnancy
There was a significant association between vitamin D-GRS and
25(OH)D levels in T3 (P = 0.004) and changes in 25(OH)D
levels during pregnancy (P = 0.018), but not with T1 25(OH)D
levels (P = 0.157). The synthesis-GRS andmetabolism-GRS had
no effect on 25(OH)D levels and changes in 25(OH)D levels
during pregnancy (P > 0.05 for all comparisons). The association
between GRSs and serum 25(OH)D levels during pregnancy are
shown in Table 3 and Fig. 3.
Association between GRSs and newborn
anthropometry
Weobserved no statistically significant association of the vitamin
D-GRS, synthesis-GRS, and metabolism-GRS with newborn
anthropometry measurements (P > 0.05 for all comparisons).
Similar finding was observed even after classifying newborn
anthropometry measurements into categorical variables (P >
0.05 for all comparisons) (Supplementary Tables 2 and 3).
Interaction between GRS and 25(OH)D
during pregnancy on newborn anthropometry
None of the interactions were statistically significant except
for the interaction between vitamin D-GRS and 25(OH)D
concentrations in T3 on newborn head circumference mea-
surement (P = 0.030). Further stratification of study partici-
pants based on head circumference cut-off points (small
heads, <35 cm and normal head, ≥35 cm) [18] showed that
mothers of neonates with head circumference < 35 cm had
significantly lower 25(OH)D levels if they carried ≥4 risk
alleles compared to those who carried ≤3 risk alleles
(Fig. 4). However, after correction for multiple testing, this
interaction was not considered statistically significant
(Table 4).
Association between SNPs and 25(OH)D
during pregnancy
Besides exploring the impact of GRS on 25(OH)D levels dur-
ing pregnancy, the individual effect of the SNPs on 25(OH)D
levels was also examined. Under a dominant genetic model,
ApaI (rs7975232) SNP showed a significant association with
25(OH)D levels in both T1 (0.047) and T3 (p = 0.043), where
A allele carriers had significantly lower 25(OH)D concentra-
tions. In addition, A allele carriers of the CYP2R1
Fig. 2 Diagram representing the study objectives. Three possible
associations and one possible interaction were examined. Broken lines
represent genetic associations and unbroken lines represent phenotypic
association and interaction between genetic risk score (GRS) and vitamin
D status on newborn anthropometry measurements, respectively.
Phenotypic association between vitamin D status and newborn
anthropometry measurements and the genetic associations between
GRS and vitamin D status and newborn anthropometry measurements
were investigated
J Diabetes Metab Disord
Ta
bl
e
1
C
ha
ra
ct
er
is
tic
s
of
st
ud
y
pa
rt
ic
ip
an
ts
V
ar
ia
bl
es
T
1
T
3
T
1
T
3
n
V
D
D
St
at
us
n
N
V
D
St
at
us
P
n
V
D
D
St
at
us
n
N
V
D
St
at
us
P
n
M
ea
n
±
S
D
n
M
ea
n
±
S
D
P
A
ge
,y
ea
rs
19
2
29
.6
0
±
5.
51
40
30
.5
3
±
6.
48
0.
41
2
87
29
.0
5
±
5.
21
99
30
.3
6
±
6.
13
0.
12
2
Sy
st
ol
ic
,m
m
H
g
19
2
11
0.
94
±
11
.1
6
40
10
7.
75
±
11
.8
7
0.
12
4
87
11
1.
36
±
10
.8
8
99
11
1.
44
±
9.
79
0.
96
2
18
6
10
7.
08
±
10
.8
4
18
6
11
1.
51
±
10
.2
6
0.
00
5
D
ia
st
ol
ic
,m
m
H
g
19
2
75
.5
7
±
7.
08
40
74
.6
3
±
7.
28
0.
45
5
87
77
.6
2
±
8.
61
99
75
.3
7
±
6.
80
0.
04
7
18
6
72
.8
6
±
7.
36
18
6
76
.6
0
±
7.
88
0.
55
3
G
A
,w
ee
ks
19
2
9.
67
±
2.
32
40
9.
48
±
2.
53
0.
66
1
87
30
.4
9
±
3.
18
99
30
.1
5
±
2.
93
0.
44
2
H
b,
g/
dL
19
2
11
.6
2
±
1.
39
40
10
.3
4
±
1.
15
0.
18
0
87
10
.8
2
±
1.
51
99
11
.1
9
±
1.
50
0.
65
0
18
6
11
.5
8
±
1.
39
18
6
11
.8
1
±
1.
36
0.
41
3
H
ei
gh
t,
cm
19
2
15
4.
51
±
5.
91
40
15
3.
59
±
6.
47
0.
40
9
87
15
4.
68
±
5.
78
99
15
3.
78
±
6.
65
0.
22
8
B
od
yw
ei
gh
t,
K
g
19
2
56
.6
1
±
11
.6
8
40
54
.8
1
±
11
.7
0
0.
38
0
87
63
.6
7
±
11
.5
8
98
64
.2
1
±
10
.7
1
0.
01
6
18
6
56
.3
2
±
11
.6
3
18
6
63
.9
3
±
11
.1
5
0.
00
1
B
M
I,
kg
/m
2
19
2
23
.5
4
±
4.
37
40
23
.0
4
±
5.
42
0.
59
0
87
23
.2
3
±
4.
56
99
23
.7
7
±
4.
56
0.
84
2
M
U
A
C
,c
m
19
2
27
.0
4
±
3.
78
40
26
.8
1
±
3.
94
0.
74
0
87
24
.6
5
±
3.
66
99
27
.9
0
±
3.
82
0.
99
4
18
6
27
.0
2
±
3.
81
18
6
27
.8
2
±
3.
80
0.
00
1
O
ut
do
or
ac
tiv
ity
,h
ou
rs
/d
ay
19
2
59
.2
2
±
51
.9
0
40
73
.8
8
±
38
.0
2
0.
04
2
87
60
.3
5
±
48
.6
5
99
64
.3
1
±
54
.5
1
0.
60
4
B
ir
th
w
ei
gh
t,
g
86
32
44
.9
0
±
46
9.
51
98
31
47
.0
9
±
45
8.
73
0.
15
5
B
ir
th
le
ng
th
,c
m
86
48
.5
9
±
3.
43
98
48
.5
3
±
3.
05
0.
89
0
H
ea
d
ci
rc
um
fe
re
nc
e,
cm
86
34
.1
0
±
2.
98
98
33
.5
5
±
1.
89
0.
12
8
G
A
at
bi
rt
h,
w
ee
ks
86
39
.0
8
±
1.
81
98
38
.7
3
±
1.
94
0.
20
9
V
D
D
vi
ta
m
in
D
de
fi
ci
en
t,
N
V
D
no
rm
al
vi
ta
m
in
D
,G
A
ge
st
at
io
na
la
ge
,B
M
Ib
od
y
m
as
s
in
de
x,
25
(O
H
)D
25
-h
yd
ro
xy
vi
ta
m
in
D
,T
1
fi
rs
tt
ri
m
es
te
r,
T3
th
ir
d
tr
im
es
te
r,
M
U
A
C
m
id
-u
pp
er
ar
m
ci
rc
um
fe
re
nc
e.
D
at
a
pr
ov
id
ed
ar
e
m
ea
n
±
st
an
da
rd
de
vi
at
io
n.
B
ol
d
nu
m
be
r
pr
es
en
te
d
as
P
<
0.
05
J Diabetes Metab Disord
(rs12794714) SNP had significantly lower levels of 25(OH)D
in both T1 (p = 0.001) and T3 (p < =0.0001). There was also a
significant association between GC (rs22282679) SNP and
25(OH)D concentrations in T3 and changes in 25(OH)D
levels during pregnancy (P < 0.001), but not in T1 (P = 081).
None of the other associations were statistically significant
(Supplementary Table 4).
Discussion
To our knowledge, this is the first study of its kind to investi-
gate whether maternal vitamin D status was associated with
newborn anthropometry measurements using a genetic ap-
proach. Our study demonstrated a high prevalence (82.80%)
of vitamin D deficiency among Indonesian pregnant mothers.
Women who had ≥4 vitamin D-decreasing risk alleles had
significantly lower levels of serum 25(OH)D during pregnan-
cy. Even though there was no direct association between GRS
and newborn anthropometric measurements, mothers of neo-
nates with head circumference < 35 cm had significantly low-
er 25(OH)D levels if they carried ≥4 risk alleles suggesting
that vitamin D deficiency during pregnancy can increase the
genetic risk of adverse newborn anthropometry outcomes.
Considering that more than half of the study participants were
vitamin D deficient (83%), establishing a vitamin D preven-
tion program for pregnant women may be considered to main-
tain optimal foetal growth and development. Our findings, if
replicated in future studies, may have a significant public
health impact on initiating strategy to raise the awareness on
the importance of vitamin D during pregnancy to prevent vi-
tamin D deficiency and its adverse pregnancy outcomes.
Recent studies have shown a significant phenotypic asso-
ciation between serum 25(OH)D levels during pregnancy and
adverse pregnancy outcomes such as gestational diabetes
mellitus, pre-eclampsia, SGA, LBW and PTB [22, 24–26].
Evidence from observational studies have suggested that low-
er maternal 25(OH)D concentrations are associatedwith LBW
Table 3 Association pregnancy
Variables 25(OH)D T1 (ng/mL) 25(OH)D T3 (ng/mL) Changes 25(OH)D (ng/mL)
Mean ± SD P Mean ± SD P Mean ± SD P
Vitamin D-GRS total score*
less than or equal 3 (n = 99) 14.77 ± 8.22 0.157 23.35 ± 10.65 0.004 8.58 ± 9.54 0.018
greater than or equal 4 (n = 85) 12.98 ± 5.40 18.74 ± 8.95 5.76 ± 9.50
Synthesis GRS score**
less than 2 (n = 137) 14.37 ± 7.65 0.182 21.80 ± 10.46 0.287 7.43 ± 9.64 0.724
greater than or equal 2 (n = 46) 12.72 ± 5.03 19.65 ± 9.06 6.93 ± 9.62
Metabolism GRS score***
less than or equal 3 (n = 147) 14.07 ± 7.55 0.655 21.63 ± 10.45 0.482 6.57 ± 9.53 0.643
greater than or equal 4 (n = 37) 13.44 ± 4.96 19.56 ± 8.73 6.11 ± 9.90
Bold number indicate P < 0.05; 25(OH)D, 25-Hydroxyvitamin D levels; T1, First trimester; T3, Third trimester
P values were adjusted for age, BMI, vitamin D supplements, sun exposure status, and geographical status
*All six SNPs in genes involved in the synthesis and metabolism of vitamin D
**Two SNPs in genes encoding proteins involved in 25(OH)D synthesis (DHCR7 and CYP2R1) included in the “Synthesis score”
***Four SNPs in genes encoding proteins involved in 25(OH)D metabolism (GC, CYP24A1, VDR) are included in the “Metabolism score”
Table 2 Association between
Vitamin D Status during
Pregnancy and Newborn
Anthropometry
Variables Newborn Anthropometries
Birth weight (g) Birth length (g) Head circumference (cm)
Sufficiency (n = 86) 3147.09 ± 458.73 48.53 ± 2.87 33.55 ± 1.89
Insufficiency (n = 63) 3246.03 ± 403.14 48.86 ± 1.89 34.21 ± 1.98
Defficiency (n = 35) 3242.86 ± 576.65 48.11 ± 5.17 33.91 ± 4.25
P value 0.301 0.618 0.386
Vitamin D status during pregnancy defined based on Institute of Medicine (IOM): sufficient (≥20 ng/mL),
insufficient (12–19.99 ng/mL), and deficient (<12 ng/mL) [17]
P values were adjusted for age, pre-pregnancy BMI, preterm status, vitamin D intake, sun exposure status and
consumption of vitamin D and calcium supplements
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[7, 27, 28]. A recent prospective cohort study in 3658 Chinese
mother-and-singleton-offspring pairs demonstrated that vita-
min D deficiency during pregnancy was associated with neo-
natal birth size and estimated to double the risk of LBW [28].
In addition, two other studies that examined serum 25(OH)D
levels during pregnancy found no association between first
trimester vitamin D status and neonatal length but found a
significant association in the third trimester [29, 30].
However, a few studies failed to show an association between
maternal 25(OH)D levels and adverse pregnancy outcomes
[29, 31–33]. These inconsistencies in findings could be due
to confounding by unknown factors and the differences in cut-
points of vitamin D status used, sample size, population
characteristics, skin pigmentation, exposure to sunlight, vita-
min D supplementation and methods to measure 25(OH)D
[24–26, 29, 31–35]. Given these limitations, we used a genetic
approach, which is less prone to confounding, to explore the
association between serum 25(OH)D levels during pregnancy
and adverse pregnancy outcomes.
One of the main findings of our study was the significant
association between GRS (≥4 risk alleles) and lower serum
25(OH)D levels in the third trimester (P = 0.004) and changes
in serum 25(OH)D levels during pregnancy. Our finding was
similar to a study in 759 Chinese Han pregnant women from
Zhoushan PregnantWomen Cohort (ZPWC) which also showed
that individuals with >3 risk alleles had significantly lower
25(OH)D levels compared to those with 1 risk allele [36].
These findings are suggestive of the fact that the vitamin D-
related genetic variants might have additive or synergistic effects
in influencing 25(OH)D concentrations in pregnant mothers.
Very few studies have assessed the association of vitamin
D-related genotypes with 25(OH)D and newborn anthropom-
etry (birth weight, birth length, head circumferences). A few
recent studies have shown that VDR gene variants influence
birth weight and risk for SGA in black and white women [7,
27]. A recent Mendelian randomization study has also shown
that polymorphisms in vitamin D-related genes, CYP2R1
[rs10741657] and DHCR7 [rs12785878], were associated
with LBW suggesting a causal link between maternal vitamin
D deficiency and neonatal birth weight [37]. Conversely, our
study found no association between GRS and newborn an-
thropometry measurements (birth weight, birth length, head
circumferences); however, mothers of neonates with small
head circumference group (<35 cm) had significantly lower
25(OH)D levels if they carried ≥4 risk alleles suggesting that
vitamin D deficiency could increase the genetic risk of adverse
neonatal outcomes. Our finding is in line with a previous
Fig. 4 Interaction between
vitamin D-GRS and 25(OH)D
levels in T3 (ng/mL) on Head
circumference. Mothers of
neonates with head
circumference < 35 cm had
significantly lower 25(OH)D
levels if they carried ≥4 risk
alleles compared to those who
carried ≤3 risk alleles (P = 0.040)
Fig. 3 Association between vitamin D-GRS and serum 25(OH)D levels in
T3. Among those who carried ≥4 risk alleles had lower serum 25(OH)D
levels in T3 compared to women with ≤3 risk alleles (P= 0.004)
J Diabetes Metab Disord
study which had also shown that mothers of neonates with
small head circumference (<35 cm) had significantly lower
levels of 25(OH)D [22]; but the previous study did not explore
the genetic susceptibility of the pregnant mothers. Future stud-
ies investigating the genetic basis of the associations between
vitamin D status during pregnancy and newborn anthropom-
etry measurements are required to confirm or refute our
findings.
While most of the genetic variants chosen for our study
have not been studied previously in relation to the risk of
adverse pregnancy outcomes, VDR gene variants (rs2228570
and rs7975232) have been shown to be associated with the
risk of adverse pregnancy outcomes such as PTB, LBW, and
SGA status [27, 38–42]. However, there are also a few studies
which failed to provide evidence for the relationship between
rs7975232 (VDR) and PTB risk [38, 39]. We were unable to
explore the association between VDR variants and PTB risk in
the present study as the PTB variable was not available for all
study participants; however, we examined other newborn an-
thropometry measurements such as birth weight, birth length
and head circumference. VDR is required for the vitamin D
metabolic pathway where its activation regulates the expres-
sion of genes involved in cell proliferation and differentiation
[43]. Studies have shown the expression of VDR in placental
tissues suggesting the role of vitamin D in reproduction and
maternal to foetal nutrient transfer mechanism [44, 45].
Hence, the beneficial effects of vitamin D on foetal transfer
mechanism can be affected by the decrease in VDR expres-
sion. Furthermore, it is possible that VDR might be a key
factor in maternal to foetal nutrient transfer mechanism and
adverse pregnancy outcomes and therefore serves as a strong
candidate gene for our study.
The current study has some limitations. Firstly, the sample
size was relatively modest; however, we were still able to
identify significant associations and interactions in 183 moth-
er and infant pairs after correction for multiple testing.
Secondly, sunlight exposure variable was a self-reported out-
door activity and hence the bias involved in assessing sun
exposure status cannot be ruled out. Thirdly, we have con-
trolled for known major confounders, but we cannot
completely exclude the possibility of other confounders such
as the impact of vitamin D-fortified foods as this information
was not collected in the present study. Compared to previous
studies [1–3, 28], our study has several strengths. Firstly, the
prospective cohort study analysis may reveal stable results and
allows the examination of gestation-specific associations of
maternal vitamin D status and newborn anthropometry.
Secondly, measurements of 25(OH)D levels in different tri-
mesters provides more information about the association be-
tween SNPs and vitamin D status during pregnancy. Fourthly,
data were collected in the same season (dry season) and hence
our study findings are unlikely to be affected by seasonal
Table 4 Interaction between GRS and 25(OH)D on Newborn Anthropometry
Interaction between the GRS and 25(OH)D T1 on newborn anthropometry measurements
Interaction between vitamin D-GRS*25(OH)D T1 on birth weight Interaction between vitamin D-GRS*25(OH)D
T1 on birth length
Interaction between vitamin D-GRS*25(OH)D
T1 on head circumference
2.72 ± 10.55
(0.797)
0.04 ± 0.06
(0.510)
0.09 ± 0.05
(0.098)
Interaction between synthesis-GRS*25(OH)D
T1 on birth weight
Interaction between synthesis-GRS*25(OH)D
T1 on birth length
Interaction between synthesis-GRS*25(OH)D
T1 on head circumference
−0.23 ± 14.19
(0.472)
−0.11 ± 0.08
(0.897)
0.07 ± 0.07
(0.312)
Interaction between metabolism-GRS*25(OH)D
T1 on birth weight
Interaction between metabolism-GRS*25(OH)D
T1 on birth length
Interaction between metabolism-GRS*25(OH)D
T1 on head circumference
−5.31 ± 15.85
(0.738)
0.121 ± 0.10
(0.214)
0.02 ± 0.08
(0.799)
Interaction between the GRS and 25(OH)D T3 on newborn anthropometry measurements
Interaction between vitamin D-GRS*25(OH)D
T3 on birth weight
Interaction between vitamin D-GRS*25(OH)D
T3 on birth length
Interaction between vitamin D-GRS*25(OH)D
T3 on head circumference
9.56 ± 6.80
(0.162)
0.06 ± 0.04
(0.199)
0.08 ± 0.03
(0.031)
Interaction between synthesis-GRS*25(OH)D
T3 on birth weight
Interaction between synthesis-GRS*25(OH)D
T3 on birth length
Interaction between synthesis-GRS*25(OH)D
T3 on head circumference
7.39 ± 8.14
(0.366)
0.04 ± 0.05
(0.426)
0.08 ± 0.04
(0.075)
Interaction between metabolism-GRS*25(OH)D
T3 on birth weight
Interaction between metabolism-GRS*25(OH)D
T3 on birth length
Interaction between metabolism-GRS*25(OH)D
T3 on head circumference
5.99 ± 9.16
(0.514)
0.04 ± 0.056
(0.475)
0.08 ± 0.05
(0.105)
T1 first trimester, T3 third trimester, 25(OH)D 25-hydroxyvitamin D
Values are beta coefficients ±standard errors. P values are provided within brackets
P values were adjusted for age, pre-pregnancy BMI, supplement consumption, gestational age at birth, and gender of the infants
J Diabetes Metab Disord
variation Thirdly, study participants were enrolled from single
ethnicity (Indonesian Minangkabau women), which avoids
genetic heterogeneity. Lastly, this is the first study of its kind
in Indonesian pregnant mothers exploring the association of
maternal vitamin D status and newborn anthropometry using a
genetic approach which is less prone to confounding. Future
research should focus on conducting large prospective studies,
Mendelian Randomization studies and clinical trials to estab-
lish the causal effect of vitamin D deficiency on adverse preg-
nancy outcomes.
Conclusion
In conclusion, we provide an evidence for an impact of
vitamin D-related genetic variations on newborn anthropom-
etry measurements through the influence of serum 25(OH)D
levels among Indonesian pregnant Minangkabau women.
Before initiating strategies for the implementation of vitamin
D supplementation programs in Indonesia to prevent adverse
pregnancy outcomes, further large studies are required to
confirm our findings.
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